METTL3 and cancer: The m6A reader IGF2BP2 recognizes the modification and increases its levels by inhibiting degradation and thus facilitating the metastatic spread of cancer.[36a] Circular RNA has been proposed as another target for METTL3 in the metastatic spread of CRC.